2,379 Shares in The Clorox Company (NYSE:CLX) Acquired by Synergy Asset Management LLC

Synergy Asset Management LLC bought a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 2,379 shares of the company's stock, valued at approximately $350,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Norges Bank bought a new stake in shares of Clorox in the fourth quarter worth $259,041,000. FMR LLC lifted its position in Clorox by 75.4% during the 4th quarter. FMR LLC now owns 1,361,758 shares of the company's stock worth $221,163,000 after buying an additional 585,526 shares in the last quarter. Marshall Wace LLP boosted its stake in shares of Clorox by 549.8% during the 4th quarter. Marshall Wace LLP now owns 542,726 shares of the company's stock worth $88,144,000 after buying an additional 459,203 shares during the last quarter. ExodusPoint Capital Management LP boosted its stake in shares of Clorox by 187.9% during the 4th quarter. ExodusPoint Capital Management LP now owns 698,900 shares of the company's stock worth $113,508,000 after buying an additional 456,114 shares during the last quarter. Finally, Man Group plc grew its holdings in shares of Clorox by 154.6% in the 4th quarter. Man Group plc now owns 570,503 shares of the company's stock valued at $92,655,000 after acquiring an additional 346,449 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company's stock.

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber purchased 4,000 shares of the firm's stock in a transaction that occurred on Wednesday, May 7th. The shares were acquired at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the purchase, the director now owns 4,000 shares of the company's stock, valued at approximately $546,280. The trade was a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.57% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the company. Morgan Stanley dropped their target price on Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Jefferies Financial Group dropped their price objective on Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research note on Thursday. Citigroup decreased their target price on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating for the company in a research note on Monday, April 14th. Evercore ISI set a $140.00 target price on shares of Clorox and gave the stock an "underperform" rating in a report on Tuesday, May 6th. Finally, Barclays cut their price target on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a research note on Wednesday, May 7th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and an average target price of $149.50.

Clorox Stock Performance

Shares of NYSE CLX traded down $1.45 during mid-day trading on Thursday, reaching $118.03. 1,829,014 shares of the company were exchanged, compared to its average volume of 1,368,834. The stock has a market capitalization of $14.55 billion, a P/E ratio of 21.19, a P/E/G ratio of 2.70 and a beta of 0.54. The company has a quick ratio of 0.44, a current ratio of 0.74 and a debt-to-equity ratio of 13.07. The company's 50-day simple moving average is $131.62 and its 200-day simple moving average is $145.61. The Clorox Company has a twelve month low of $117.38 and a twelve month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a net margin of 9.89% and a return on equity of 324.23%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the prior year, the company earned $1.71 earnings per share. The firm's revenue was down 8.0% compared to the same quarter last year. As a group, research analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.